Deals
Japan's Daiichi Sankyo to acquire US biopharma Ambit Biosciences
Japanese drugmaker Daiichi Sankyo Co Ltd (4568.T) has agreed to acquire U.S. biopharmaceutical company Ambit Biosciences Corp (AMBI.O) in a deal valued up to $410 million as it looks to build its presence in oncology, the companies said.
Alibaba pays $459 million for stake in Chinese hotel tech company
Alibaba Group Holding Ltd, in its first big investment since raising $25 billion in a record-breaking New York initial public offering, has bought 15 percent of Chinese hospitality technology provider Beijing Shiji Information Technology Co Ltd for 2.81 billion yuan ($458.66 million).
Pimco sees $10 billion in withdrawals after Gross exit: WSJ
Bill Gross's exit from the investment firm Pimco had an immediate impact on the company, with investors withdrawing about $10 billion following the announcement, the Wall Street Journal reported, citing a person familiar with the matter.
Yahoo-AOL merger proposal: recipe for revival, or stagnation?
A proposed merger of Internet pioneers AOL Inc and Yahoo Inc could create a nimbler player in Web video, but strong growth, the measure of success in Silicon Valley, would remain elusive.




